M.D. Anderson reveals blood test to detect ovarian cancer

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

HOUSTON, TX – In a city known for its medical breakthroughs, it shouldn’t come as a surprise that the folks at M.D. Anderson Cancer Center are at it again. Researchers at Houston’s very own say they’ve isolated a protein that could help predict ovarian cancer from a simple blood test.

The protein, known as CA-125, has been used to detect the recurrence of ovarian cancer in patients who’ve already been treated. But an 11-year study conducted by M.D. Anderson has determined that the same protein can also be used as an early-detection mechanism

More than 22,000 women will be diagnosed with ovarian cancer in the U.S. this year — most not until the disease is already in its advanced stages. What makes the discovery exciting is the understanding that if caught early, ovarian cancer is not only treatable, but curable. Meaning that a simple blood test done early, could lead to a longer life.